All Stories

  1. Voriconazole nanosuspension-loaded ocular bilayer dissolving microneedle patch for the management of fungal keratitis
  2. Nanocrystal-loaded dissolving microneedles: A novel transdermal strategy for long-acting tizanidine administration
  3. Nano-PhotoCrystals (Photosensitive Nanocrystals) of Aloe Emodin Combined with Dissolving Microneedles for Dual Smart Targeting of Acute Bacterial Skin and Soft Tissue Infections
  4. QbD-based development of extended-release floating furosemide tablets: Formulation and in vitro/in vivo evaluation
  5. Sub-150 nm drug nanocrystals produced using a milligram-scale media mill
  6. Correction to “Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis”
  7. Lymphatic-targeted amphotericin B nanocrystals delivered using microarray patches applied to cutaneous leishmaniasis
  8. Rasagiline mesylate-based microneedle patches: A patient-friendly treatment regimen for Parkinson’s disease
  9. Author Correction: Microneedle-based biosensing
  10. Covalent Grafting of Hyaluronic Acid on Drug Nanocrystals - Application in Mucosal Delivery
  11. Versatile and sensitive dual-detection HPLC method for rapid quantification of apomorphine hydrochloride: application to ex vivo percutaneous permeation and deposition studies utilising novel transdermal pressure-sensitive adhesive patches
  12. A dynamic duo comes of age: Nanocrystals and microneedles for hydrophobic drug delivery
  13. Super-fast production of drug nanocrystals: Dual asymmetric centrifugation-enabled media milling applied to high throughput formulation screening
  14. Progress in the production of nanocrystals through miniaturized milling methods
  15. 3D-printed acyclovir nanocrystals: An advanced approach to herpes simplex treatment
  16. Bimodal Dissolving Microneedles with Nanoparticle Coating and Encapsulation for Extended Dual‐Drug Delivery
  17. Enhanced in vivo performance of topical ocular acetazolamide nanocrystals: A novel approach for glaucoma treatment
  18. Application of microarray patches for the transdermal administration of psychedelic drugs in micro-doses
  19. In vivo pharmacokinetic study and PBPK modeling: Comparison between 3D-printed nanocrystals and solid dispersions
  20. Hydrogels in Drug Delivery
  21. Advanced drug delivery systems for the management of local conditions
  22. A novel temperature-controlled media milling device to produce drug nanocrystals at the laboratory scale
  23. Olive mill wastewater: From by-product to smart antioxidant material
  24. Enhanced long-acting simvastatin delivery via effervescent powder-carrying hollow microneedles and nanocrystal-loaded microneedles
  25. Novel long-acting treatment for schizophrenia based on paliperidone dissolving and implantable microarray patches
  26. Atorvastatin-Loaded Dissolving Microarray Patches for Long-Acting Microdepot Delivery: Comparison of Nanoparticle and Microparticle Drug Formulations
  27. Corrigendum to “Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch” [Journal of Controlled Release 372 (2024) 304–317]
  28. Mucoadhesive Itraconazole Nanocrystals With Precise Control of Surface Charge Incorporated to Chitosan Films for Buccal Drug Delivery
  29. Usefulness of a murine model of hepatic cystic echinococcosis for preclinical drug trials: Efficacy of albendazole vs albendazole nanocrystals
  30. Unveiling the Potential of Surface Polymerized Drug Nanocrystals in Targeted Delivery
  31. Dissolving microarray patches loaded with a rotigotine nanosuspension: A potential alternative to Neupro® patch
  32. Publisher Correction: Microneedle-based biosensing
  33. Dissolving microarray patches for transdermal delivery of risperidone for schizophrenia management
  34. Systemic delivery of bictegravir and tenofovir alafenamide using dissolving microneedles for HIV preexposure prophylaxis
  35. Novel nano-in-micro fabrication technique of diclofenac nanoparticles loaded microneedle patches for localised and systemic drug delivery
  36. Calcipotriol Nanosuspension-Loaded Trilayer Dissolving Microneedle Patches for the Treatment of Psoriasis: In Vitro Delivery and In Vivo Antipsoriatic Activity Studies
  37. Folic Acid-Decorated Nanocrystals as Highly Loaded Trojan Horses to Target Cancer Cells
  38. Transdermal Delivery of Pramipexole Using Microneedle Technology for the Potential Treatment of Parkinson’s Disease
  39. Intradermal delivery of the antiretroviral drugs cabotegravir and rilpivirine by dissolving microarray patches: Investigation of lymphatic uptake
  40. Preparation of glyburide nanocrystals with improved dissolution properties by dry-ball- and wet-bead- milling: Systematic comparison by experimental design of the performance of the two methods
  41. Significant progress in improving Atorvastatin dissolution rate: Physicochemical characterization and stability assessment of self-dispersible Atorvastatin/Tween 80® nanocrystals formulated through wet milling and freeze-drying
  42. Curcumin nanocrystals-in-nanofibres as a promising platform for the management of periodontal disease
  43. Formulation and optimization of pH-sensitive nanocrystals for improved oral delivery
  44. Microneedles for advanced ocular drug delivery
  45. Long-acting microneedle formulations
  46. Microneedle-based biosensing
  47. Development of dissolving microneedles for intradermal delivery of the long-acting antiretroviral drug bictegravir
  48. Polymeric Microarray Patches for Enhanced Transdermal Delivery of the Poorly Soluble Drug Olanzapine
  49. Formulation of antiretroviral nanocrystals and development into a microneedle delivery system for potential treatment of HIV-associated neurocognitive disorder (HAND)
  50. Design and Development of Sublingual Printlets Containing Domperidone Nanocrystals Using 3D Melting Solidification Printing Process (MESO-PP)
  51. Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina
  52. Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration
  53. Correction to “Nanodiamonds Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases”
  54. Deferasirox Nanosuspension Loaded Dissolving Microneedles for Intradermal Delivery
  55. Bioadhesive eutectogels supporting drug nanocrystals for long-acting delivery to mucosal tissues
  56. On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles
  57. Spray-drying-microencapsulated Minthostachys verticillata essential oil and limonene as innovative adjuvant strategy to bovine mastitis vaccines
  58. Ring inserts as a useful strategy to prepare tip-loaded microneedles for long-acting drug delivery with application in HIV pre-exposure prophylaxis
  59. Trilayer dissolving polymeric microneedle array loading Rose Bengal transfersomes as a novel adjuvant in early-stage cutaneous melanoma management
  60. Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis
  61. Nanosuspension-loaded dissolving bilayer microneedles for hydrophobic drug delivery to the posterior segment of the eye
  62. Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes
  63. HPLC-MS method for simultaneous quantification of the antiretroviral agents rilpivirine and cabotegravir in rat plasma and tissues
  64. 3D-printed implantable devices with biodegradable rate-controlling membrane for sustained delivery of hydrophobic drugs
  65. Nanodiamond Integration into Niosomes as an Emerging and Efficient Gene Therapy Nanoplatform for Central Nervous System Diseases
  66. Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches
  67. Nanocrystal-based 3D-printed tablets: Semi-solid extrusion using melting solidification printing process (MESO-PP) for oral administration of poorly soluble drugs
  68. Improving the in vitro dissolution rate and pharmacokinetic performance of fenbendazole in sheep using drug nanocrystals
  69. 3D-Printed Nanocrystals for Oral Administration of the Drugs
  70. Manufacturing Techniques for Nanoparticles in Drug Delivery
  71. Novel transdermal bioadhesive surfactant-based system for release and solubility improvement of antimalarial drugs artemether-lumefantrine
  72. Formulation, spray-drying and physicochemical characterization of functional powders loaded with chia seed oil and prepared by complex coacervation
  73. Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride
  74. Albendazole Nanocrystal-Based Dissolving Microneedles with Improved Pharmacokinetic Performance for Enhanced Treatment of Cystic Echinococcosis
  75. The role of microneedle arrays in drug delivery and patient monitoring to prevent diabetes induced fibrosis
  76. Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe
  77. Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii
  78. Microneedle array systems for long-acting drug delivery
  79. Selective delivery of silver nanoparticles for improved treatment of biofilm skin infection using bacteria-responsive microparticles loaded into dissolving microneedles
  80. Microarray Patches: Poking a Hole in the Challenges Faced When Delivering Poorly Soluble Drugs
  81. Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis
  82. Nanocrystals of Novel Valerolactam-Fenbendazole Hybrid with Improved in vitro Dissolution Performance
  83. Ricobendazole nanocrystals obtained by media milling and spray drying: Pharmacokinetic comparison with the micronized form of the drug
  84. Self-dispersible nanocrystals of azoxystrobin and cyproconazole with increased efficacy against soilborne fungal pathogens isolated from peanut crops
  85. Development of solid self-emulsifying drug delivery systems (SEDDS) to improve the solubility of resveratrol
  86. A Natural Peanut Edible Coating Enhances the Chemical and Sensory Stability of Roasted Peanuts
  87. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior
  88. Controlled release and antioxidant activity of chitosan or its glucosamine water-soluble derivative microcapsules loaded with quercetin
  89. pH-responsive casein-based films and their application as functional coatings in solid dosage formulations
  90. Albendazole nanocrystals with improved pharmacokinetic performance in mice
  91. Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice
  92. Antioxidant Stability Study of Oregano Essential Oil Microcapsules Prepared by Spray-Drying
  93. Nanocrystals improve the PK and therapeutic response of albendazole in dogs
  94. Study of the preparation process and variation of wall components in chia ( Salvia hispanica L.) oil microencapsulation
  95. Self-dispersible nanocrystals of albendazole produced by high pressure homogenization and spray-drying
  96. Pharmacokinetic Assessment of Novel Controlled Release Formulations of Ricobendazole Intended for Oral Administration in Dogs